Completed
to Evaluate the Safety and Efficacy of Pitavastatin in Patients With IFG and Hyperlipidemia
NCT02056847
- Conditions
- Dyslipidemias, HbA1c Level Associated With Lipid Compositions, Hyperlipidemias, +3 more
- Locations
-
- JW pharmaceutical Seoul, South Korea